Independent thinking for complex markets and current events
On November 19, 2025, the Food and Drug Administration granted accelerated approval to sevabertinib (Hyrnuo, Bayer HealthCare Pharmaceuticals Inc.), a kinase inhibitor, for adults with locally advanced or metastatic, non-squamous non-small cell lung cancer (NSCLC) whose tumors have HER2 (ERBB2) tyrosine kinase domain (TKD) activating mutations, as detected by an FDA-approved test, and who have …
AI DISCOVERS REVOLUTIONARY NEW WAY TO REVERSE LUNG DAMAGE An AI system didn’t just design a new drug for pulmonary fibrosis; it first figured out which protein was causing the damage (TNIK), then designed a molecule to shut it down. In a 12-week trial, patients on the highest dose gained almost 100 ml of lung …
A lung from a genetically modified pig has been transplanted into a person for the first time1. The recipient, a 39-year-old man in China, was brain dead, but the organ survived for nine days. At least half a dozen people in the United States and China have received organs from genome-edited pigs, including hearts, kidneys, …
Health officials in Ohio and Massachusetts are warning about an increase in pneumonia cases among children — but experts say there isn’t a connection between this outbreak and the one happening in China. In a press release Thursday, officials in Ohio’s Warren County (located between Cincinnati and Dayton) shared an update on the outbreak there, …